Literature DB >> 24413043

Systemic cytokine levels show limited correlation with risk of HIV-1 acquisition.

Dara A Lehman1, Keshet Ronen, Catherine A Blish, Jared M Baeten, Zahra Jalalian-Lechak, Walter Jaoko, Kishorchandra Mandaliya, Barbra A Richardson, R Scott McClelland, Julie Overbaugh.   

Abstract

It has been hypothesized that immune activation and inflammation may increase HIV-1 susceptibility, and that cytokines may be useful biomarkers for risk. Within a prospective cohort, we conducted a nested case-control analysis of plasma cytokine levels among women who acquired HIV-1 <3 months after sampling, compared with 3 different control groups. We observed associations between lower interleukin (IL)-6 and IL-10 and higher IL-7 levels with HIV-1 acquisition, however, these associations were inconsistent when comparing with different control groups. Inconsistent results within our study and among previous studies suggest that reproducible findings are needed before cytokines are useful biomarkers for HIV-1 susceptibility.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24413043      PMCID: PMC4020985          DOI: 10.1097/QAI.0000000000000104

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  24 in total

1.  Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women.

Authors:  M Biasin; S L Caputo; L Speciale; F Colombo; L Racioppi; A Zagliani; C Blé; F Vichi; L Cianferoni; A M Masci; M L Villa; P Ferrante; F Mazzotta; M Clerici
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

Review 2.  The 'immunologic advantage' of HIV-exposed seronegative individuals.

Authors:  Masaaki Miyazawa; Lucia Lopalco; Francesco Mazzotta; Sergio Lo Caputo; Francisco Veas; Mario Clerici
Journal:  AIDS       Date:  2009-01-14       Impact factor: 4.177

3.  HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathways.

Authors:  Rachel P Simmons; Eileen P Scully; Erin E Groden; Kelly B Arnold; J Judy Chang; Kim Lane; Jeff Lifson; Eric Rosenberg; Douglas A Lauffenburger; Marcus Altfeld
Journal:  AIDS       Date:  2013-10-23       Impact factor: 4.177

4.  Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T-cell responses in the female genital tract during chronic HIV infection.

Authors:  Pamela P Gumbi; Nonhlanhla N Nkwanyana; Alfred Bere; Wendy A Burgers; Clive M Gray; Anna-Lise Williamson; Margaret Hoffman; David Coetzee; Lynette Denny; Jo-Ann S Passmore
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

Review 5.  Mucosal innate immunity as a determinant of HIV susceptibility.

Authors:  Shehzad M Iqbal; Rupert Kaul
Journal:  Am J Reprod Immunol       Date:  2008-01       Impact factor: 3.886

6.  Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.

Authors:  Anna Suy; Pedro Castro; Meritxell Nomdedeu; Felipe García; Anna López; Emilio Fumero; Teresa Gallart; Lucia Lopalco; Oriol Coll; José M Gatell; Montserrat Plana
Journal:  J Infect Dis       Date:  2007-09-17       Impact factor: 5.226

7.  Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1.

Authors:  H L Martin; P M Nyange; B A Richardson; L Lavreys; K Mandaliya; D J Jackson; J O Ndinya-Achola; J Kreiss
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

Review 8.  Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis.

Authors:  Kimberly A Powers; Charles Poole; Audrey E Pettifor; Myron S Cohen
Journal:  Lancet Infect Dis       Date:  2008-08-04       Impact factor: 25.071

9.  Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons.

Authors:  Hui-Lee Wong; Ruth M Pfeiffer; Thomas R Fears; Roel Vermeulen; Shaoquan Ji; Charles S Rabkin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

10.  An evaluation of commercial fluorescent bead-based luminex cytokine assays.

Authors:  Joel Fleury Djoba Siawaya; Teri Roberts; Chantal Babb; Gillian Black; Hawa Jande Golakai; Kim Stanley; Nchinya Bennedict Bapela; Eileen Hoal; Shreemanta Parida; Paul van Helden; Gerhard Walzl
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

View more
  4 in total

1.  Concomitant Imbalances of Systemic and Mucosal Immunity Increase HIV Acquisition Risk.

Authors:  Charles S Morrison; Pai-Lien Chen; Hidemi Yamamoto; Xiaoming Gao; Tsungai Chipato; Sharon Anderson; Robert Barbieri; Robert Salata; Gustavo F Doncel; Raina N Fichorova
Journal:  J Acquir Immune Defic Syndr       Date:  2020-05-01       Impact factor: 3.731

2.  Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls.

Authors:  Costin Tomescu; Kelly E Seaton; Peter Smith; Mack Taylor; Georgia D Tomaras; David S Metzger; Luis J Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2015-03-01       Impact factor: 3.731

3.  The Effects of Hormones and Vaginal Microflora on the Glycome of the Female Genital Tract: Cervical-Vaginal Fluid.

Authors:  Bernard J Moncla; Catherine A Chappell; Brian M Debo; Leslie A Meyn
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

4.  Genital-Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women.

Authors:  Lenine J P Liebenberg; Lindi Masson; Kelly B Arnold; Lyle R Mckinnon; Lise Werner; Elizabeth Proctor; Derseree Archary; Leila E Mansoor; Douglas A Lauffenburger; Quarraisha Abdool Karim; Salim S Abdool Karim; Jo-Ann S Passmore
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.